of acute renal failure (ARF ) [1] [2] [3] [4] [5] . Dialysis membranes have been found to activate a variety of humoral Background. It has been reported that patients with acute renal failure (ARF ) requiring haemodialysis and cellular pro-inflammatory systems [6] [7] [8] [9] . These processes are currently referred to as bio(in)compatshow an improved recovery of renal function when the dialysis treatment is performed using a biocompatible ibility-related problems [10] , and these activated systems, in turn, produce or release a variety of membrane rather than a bioincompatible membrane. However, most recent published human trials have not inflammatory products which can be injurious to tissues [11] . For several years there has been concern in been able to confirm these findings.
Material and methods Introduction
A cohort of 95 patients with end-stage renal failure on Exposure to less biocompatible cellulosic dialysis memmaintenance dialysis who had undergone cadaveric renal branes has been suggested to adversely affect the course transplantation were prospectively studied over a 24-month period (from February 1995 to February 1997). Of these, 53 bicarbonate-based dialysate with less than 200 CFU/ml and endotoxin content <5EU/ml, in monthly analysis, as a part of the routine dialysis programme throughout the study). the postoperative day at which the first haemodialysis session was performed, the number of haemodialysis sessions required prior to the recovery of renal function
Results
(6.67±2.79 vs 6.05±2.40), the number of oliguric days (16.25±5.14 vs 14.40±4.57) and the number of hosFifty-three of the 95 patients required haemodialysis pital days (33.38±12.85 vs 30.10±11.00) in each of after renal transplantation. Nine patients were excluded from this study due to biopsy-confirmed acute vascular Table 2 . There was no significant difference in mean patients' weight, mean immunosuppressive drugs and mean cyclosporine blood level between cuprophane HD, haemodialysis.
Effect of dialyser biocompatibility 711 the two groups of patients were similar. There was function occurred was not influenced by the membrane applied. Our data are therefore in contrast to the also no difference in long-term allograft outcome, and in cumulative percent of patients with recovery from earlier publications [14, 15, 20] ; they reported that the application of a biocompatible membrane significantly acute renal failure along post-transplant days (Figure 1 [15, 20] . The authors according to the dialysis membrane used, (polyamide reported on the identification of one factor to account or cuprophane), and the study did not find any differfor morbidity/mortality in patients dialysed for acute ence between membranes with regard to survival, the renal failure, namely the biocompatibility of dialysis number of dialysis sessions and general morbidity. membranes. Among patients with ARF requiring Gastaldello et al. [17] designed a trial to evaluate haemodialysis, the use of a biocompatible membrane the use of an incompatible membrane (cuprophane), a (polymethylmethacrylate, PMMA and polyacrylobiocompatible low-flux membrane (polysulfone) and a nitrile, PAN ), as compared with the cuprophane more biocompatible high-flux membrane (polysulfone) membrane, resulted in an improved recovery of renal in patients with ARF; the recovery of renal function function, and had a higher rate of patient survival. In and survival rate did not differ significantly between addition, patients treated with biocompatible memthe three groups. Valeri performed a 2-year randomized branes were reported as suffering a significantly lower study to analyse the effects of dialysis membrane type incidence of bacterial infections, as well as a lower in 30 patients who suffered ARF post cadaveric renal relative and absolute mortality rate due to sepsis transplant [21] . No differences were found between [16, 18] . Furthermore, most recent trials, including the 16 patients dialysed with cuprophane membranes patients in ICU and cadaveric renal transplant recipiand the 14 patients dialysed with PMMA dialysers ents, have not been able to confirm these findings with regard to the mean time before recovery from [17, 21, 22] . ARF (9.1 days vs 8.8 days, P=n.s.) or the mean Our results demonstrate that the use of a more number of dialysis sessions required (3.7 vs 3.4, P= biocompatible membrane had no influence on the n.s.). Moreover, no difference was reported between course of ARF (post-operative ischaemic acute tubular the two groups of patients concerning the long-term necrosis) in patients receiving a cadaveric renal transoutcome of the allograft in terms of nadir serum plant requiring supportive haemodialysis in the immecreatinine concentration, number of episodes of acute diate post-transplant setting. In addition, the mean rejection or number of cases with rejection. Recently, dialytic time after transplantation, and the number of the same group has also reported similar results in 53 dialysis treatments needed before recovery of renal patients randomized to cuprophane, Hemophan (a membrane of intermediate biocompatibility) or PMMA hollow-fibre dialyser [22] . It is, of course, a difficult task to put forward any explanations for the different results of these studies. Important questions refer to stratifying patients by the severity of illness, the faster recovery of renal function in ARF after renal transplantation, which is of shorter duration than the average recovery time reported in other ARF trials, the small number of oliguric cases among ARF in renal transplant recipients, the effect of immunossupressive drugs which could attenuate some of the end organ inflammatory effects of complement and leukocyte activation on the injured kidneys, and the systemic toxic deleterious effect of bioincompatible membranes on other injured target organs as lung, heart and immune system, in critically ill patients with multi-organ failure [22] . Therefore, further studies are necessary to clearly determine the relationship between biocompatibility issues and the course of ARF.
In conclusion, our data refute the hypothesis that exposure to cellulosic dialysis membranes of poor 
